Results 151 to 160 of about 11,443 (200)

Nanoscale Mechanical and Morphological Characterization of Ebolavirus-like Particles: Implications for Therapeutic Development. [PDF]

Int J Mol Sci
Hargrove H, Torres-Hurtado SA, Maury WJ, Zhang XF.   +3 more
europepmc   +1 more source

Spatial risks of Orthoebolavirus spillover vary based on outbreak type. [PDF]

Int J Infect Dis
Sundaram M, Stephens PR.
europepmc   +1 more source

When Combatting Ebola and other Outbreak-Prone Pathogens, Global Health is American's Health. [PDF]

Am J Trop Med Hyg
Bausch DG, Heymann D.
europepmc   +1 more source

The Development of Ebola Virus Outbreaks: A Review of Epidemiological Trends, Clinical Features, and Treatment Advances. [PDF]

Cureus
Mohd OB, Sawaqed S, Kundu M, Ghannam RA, Mohd AB, AlSamhori JF, Musallam OK, Altiti A, Hasan H, Khaity A.   +9 more
europepmc   +1 more source

Utility of TaqMan Array Cards for detection of acute febrile illness etiologies in patients suspected of viral hemorrhagic fever infections. [PDF]

BMC Infect Dis
Akurut GG, Nyakarahuka L, Whitmer S, Namanya D, Kamugisha K, Mulei S, Baluku J, Tumusime A, Kyondo J, Patel K, Lutwama JJ, Shoemaker T, Montgomery J, Klena JD, Balinandi S.   +14 more
europepmc   +1 more source

Design of a stapled peptide that binds to the Ebola virus matrix protein dimer interface. [PDF]

RSC Chem Biol
Saxena R, Wright MM, Rathman BM, Karki U, Chapagain PP, Del Valle JR, Stahelin RV.   +6 more
europepmc   +1 more source

Going batty: US bat imports raise concerns for species conservation and human health. [PDF]

One Health
Tarango M, Kolby JE, Goodman OLB, Anderson CJ, Tinsman J, Kirkey J, Liew A, Jones M, Firth C, Reaser JK.   +9 more
europepmc   +1 more source

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches). [PDF]

BMC Med
Watson CH, Gsell PS, Hall Y, Camacho A, Riveros X, Enwere G, Vicari A, Nadlaou SD, Toure A, Sani IM, Diallo A, Kolie C, Duraffour S, Ifono K, Maomou A, Dore K, Djidonou HA, Bagayoko A, Damey PP, Camara MN, Diallo FB, Oumar FT, Toure K, Diaby ML, Sylla L, Conde D, Kaba IL, Tipton T, Eggo RM, Marks M, Roberts CH, Strecker T, Günther S, Keita S, Edmunds WJ, Carroll MW, Henao-Restrepo AM.   +36 more
europepmc   +1 more source

Overview of vaccines for adults authorized, recommended, and implemented in the European Union. [PDF]

NPJ Vaccines
Pattyn J, Launay O, Steffen R, Weinberger B, Gabutti G, Ihan A, Weinke T, Jancoriene L, Bonanni P, Van Damme P.   +9 more
europepmc   +1 more source

Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site. [PDF]

iScience
Wang LL, Keiser P, Yang D, Seravalli J, Patten JJ, Eaton B, Anderson D, Liu Y, Holbrook MR, Smith AB, Davey RA, Xiang SH.   +11 more
europepmc   +1 more source